Evidence map›Paper›PMID 32977392›Full record

ArticleMolecules (Basel, Switzerland)2020

The Effect of Modified Porcine Surfactant Alone or in Combination with Polymyxin B on Lung Homeostasis in LPS-Challenged and Mechanically Ventilated Adult Rats.

Maros Kolomaznik, Jana Kopincova, Zuzana Nova, Juliana Topercerova, Ivan Zila, Pavol Mikolka, Petra Kosutova, Katarina Matasova, Henrieta Skovierova, Marian Grendar and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Biomedicines · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Maros KolomaznikBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.ORCID 0000-0003-0992-3058
Jana KopincovaDepartment of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.
Zuzana NovaDepartment of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.ORCID 0000-0002-0804-4185
Juliana TopercerovaDepartment of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.
Ivan ZilaDepartment of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.
Pavol MikolkaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.ORCID 0000-0001-8485-4748
Petra KosutovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.ORCID 0000-0002-1596-3702
Katarina MatasovaClinic of Neonatology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and Martin University Hospital, 03601 Martin, Slovakia.
Henrieta SkovierovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.
Marian GrendarBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.
Daniela MokraDepartment of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.ORCID 0000-0001-5885-6360
Andrea CalkovskaDepartment of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 03601 Martin, Slovakia.ORCID 0000-0003-4113-3005
Comenius University Bratislava · SKMartin University Hospital · SK

Funding

Agentúra na Podporu Výskumu a Vývoja 15-0075Agentúra na Podporu Výskumu a Vývoja 17-0250Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0055/19
6 · The paper itself

Abstract

The study aimed to prove the hypothesis that exogenous surfactant and an antibiotic polymyxin B (PxB) can more effectively reduce lipopolysaccharide (LPS)-induced acute lung injury (ALI) than surfactant treatment alone, and to evaluate the effect of this treatment on the gene expression of surfactant proteins (SPs). Anesthetized rats were intratracheally instilled with different doses of LPS to induce ALI. Animals with LPS 500 μg/kg have been treated with exogenous surfactant (poractant alfa, Curosurf

Indexed as

Respiration, ArtificialAnimalsAnti-Bacterial AgentsBiomarkersCytokinesDrug InteractionsGene Expression RegulationHomeostasisLeukocyte CountLipopolysaccharidesLungOxidative StressPolymyxin BRatsSurface-Active AgentsSwineAnti-Bacterial AgentsBiomarkersCytokinesLipopolysaccharidesPolymyxin BSurface-Active AgentsARDSbacterial lipopolysaccharidepulmonary surfactantsurfactant proteins

Identifiers

PMID32977392
PMCPMC7582504
OpenAlexW3088617925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.